LONDON, July 3, 2025 /PRNewswire/ -- Boldyn Networks (Boldyn), a global leader in private networks and shared communications infrastructure, has been recognised as a Major Player...
MIAMI, July 03, 2025 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today announces that it has received a Notification of Disposition of Collateral (the "Notice") from Anthony J. DePaul, as Agent and Secured Party under the Pledge Agreement dated as of October 1, 2021 between CSAC Acquisition PA II Corp., a subsidiary of the Company, and the Agent (the "Pledge Agreement"). Separately, the Company announces that it has entered into an additional amendment (the “Second Amendment”) to the previously disclosed Limited Waiver Agreement dated June 6, 2025 (the “Original Agreement”), as amended on June 19, 2025 (the “First Amendment”).
INRS team is exploring the potential of saponins, a group of natural molecules found in many plants
LAVAL, QC, July 3, 2025 /CNW/ - Innovative, nontoxic...
Beauty and Peril of Vanishing Glaciers Taking Centre Stage in Onewater's Global Photography Exhibition, Urging Climate Action
NEUÖTTING, Germany, July 3, 2025 /PRNewswire/ -- Breathtaking...
BOGOTA, Colombia, July 2, 2025 /PRNewswire/ -- Ecopetrol S.A. (BVC: ECOPETROL; NYSE: EC, the "Company" or "Ecopetrol") reports that, on June 3, 2025, the...
The sleep apnea market growth is driven by rising awareness, technological advancements, and demand for personalized care. Companies innovate therapies and solutions for better...
SAN DIEGO, July 2, 2025 /PRNewswire/ -- A new prospective study published in BMC Cancer demonstrates that a novel blood-based multi-omics test, SeekInClarity, can accurately...
Invivyd Forms SPEAR (Spike Protein Elimination and Recovery) Study Group with Researches to Assess Effects of Monoclonal Antibody Therapy for Long COVID
The recent Senate decision to reject an amendment that sought to impose a decade-long moratorium on state-level AI regulation underscores a pivotal moment for...
The NOX-targeted therapy market is expected to expand significantly over the upcoming years as more therapies move into late-stage development and gain regulatory approval....
The NOX-targeted therapy market is expected to expand significantly over the upcoming years as more therapies move into late-stage development and gain regulatory approval....
DALLAS, July 1, 2025 /PRNewswire/ -- The Highland Opportunities and Income Fund (NYSE: HFRO) ("HFRO" or the "Fund") today announced its regular monthly distribution...